Joint Flex
Joint Flex, licence 80058414: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Weider Glucosamine Chondroitin MSM
- Licence holder
- Weider Global Nutrition LLC
- NPN or DIN-HM
- 80058414
- Status
- Active licence
- Licence date
- 23 February 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 200.0 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : exosquelettes de crevettes | 500.0 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 500.0 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : exosquelettes de homards | 500.0 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crabe | 500.0 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 400.0 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Croscarmellose de sodium, Cellulose microcristalline, Phosphate de calcium dibasique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve (joint) pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80058414
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.